Jaime Lecomte
Psychiatric/Mental Health · Phoenix, AZNPI 1740858778
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Curonix LLC at 47.9% of the total. Reporting peaked in 2023 at $9,425 and has fallen 97.9% since, to $202 in 2025. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $73.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curonix LLC$7K
- Nevro Corp.$2K
- Vertos Medical, Inc.$2K
- Boston Scientific$1K
- Spinal Simplicity, LLC$1K
- AbbVie$669
- plus $2K from 17 others
What the payments were for
- Consulting fees$5,65538%
- Travel & lodging$3,81925%
- Food & beverage$5,58337%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Curonix LLC | 23 | $7,210 |
| Nevro Corp. | 17 | $1,689 |
| Vertos Medical, Inc. | 9 | $1,684 |
| Boston Scientific | 16 | $1,021 |
| Spinal Simplicity, LLC | 22 | $1,012 |
| AbbVie(2 entities) | 21 | $669 |
| Collegium Pharmaceutical, Inc. | 33 | $490 |
| Saluda Medical Americas, Inc. | 10 | $289 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $238 |
| Pfizer | 9 | $205 |
| Abbott | 7 | $147 |
| Scilex Pharmaceuticals Inc. | 8 | $140 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| GRT US Holding, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Globus Medical | 1 | $21 |
| MML US, Inc. | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,057 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 137 | $101,958 |
| Xtampza ErOxycodone Myristate | 88 | $44,771 |
| RelistorMethylnaltrexone Bromide | 15 | $35,145 |
| Buprenorphine | 65 | $22,155 |
| BotoxOnabotulinumtoxina | 11 | $16,277 |
| Nurtec OdtRimegepant Sulfate | 13 | $14,011 |
| NucyntaTapentadol Hcl | 17 | $13,233 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 326 | $10,219 |
| Lidocaine | 40 | $8,842 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 271 | $8,131 |
| Oxycodone Hcl | 413 | $7,701 |
| MovantikNaloxegol Oxalate | 18 | $6,473 |
| Nucynta ErTapentadol Hcl | 11 | $5,148 |
| Morphine Sulfate ErMorphine Sulfate | 227 | $4,706 |
| Fentanyl | 27 | $3,365 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta, Nucynta Er | $490 | $165,110253 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $238 | $35,14515 claims |
| AbbVieBotox | $669 | $16,27711 claims |
| PfizerNurtec Odt | $205 | $14,01113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Phoenix
- Elizabeth ElliottPhoenix$363K
- Russell HorningPhoenix$254K
- Claire ReecePhoenix$88K
- Luis FongPhoenix$59K
- Marilizabeth BirkPhoenix$34K
- Roger MayorgaPhoenix$10K
- Elena SassPhoenix$9K
- Martha SerranoPhoenix$8K
- Bonnie VogesPhoenix$7K
- Brandy HammondPhoenix$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.